The "tocopherol-acetaminophen reaction" - A new [1,4]-rearrangement discovered in vitamin E chemistry

European Journal of Organic Chemistry

Volumn , Issue 5, 2001, Pages 947-955

  Rosenau, Thomas ^a   Kosma, Paul ^a  

^a UNIVERSITY OF NATURAL RESOURCES AND LIFE SCIENCES   (Austria)

Author keywords

Isotopic labeling; Protecting groups; Reaction mechanisms; Rearrangements; Vitamins

Indexed keywords

ALPHA TOCOPHEROL; PARACETAMOL;

AROMATIZATION; ARTICLE; CHEMICAL REACTION; MOLECULAR INTERACTION; OXIDATION REDUCTION REACTION; REACTION ANALYSIS; SOLUBILITY; STRUCTURE ANALYSIS; VITAMIN METABOLISM;

EID: 0035114832     PISSN: 1434193X     EISSN: None     Source Type: Journal    
DOI: 10.1002/1099-0690(200103)2001:5<947::AID-EJOC947>3.0.CO;2-R     Document Type: Article

References (32)

1. For general preparation procedures see: T. Rosenau, W. D. Habicher, J. Prakt. Chem. 1996, 338, 647-653.
2. T. Rosenau, C. L. Chen, W. D. Habicher, J. Org. Chem. 1995, 60, 8120-8122.
3. T. Rosenau, T. Ph. D. Dissertation, Dresden Univ. of Technology, Germany, 1997.
4. T. Rosenau, W. D. Habicher, Tetrahedron 1995, 51, 7919-7926.
5. [5a] For preparation see: D. R. Nelan, C. D. Robeson, J. Am. Chem. Soc. 1962, 84, 2963-2965.
6. [5b] Detailed NMR spectroscopic data are given in: H. M. Fales, J. Chem. Soc., Perkin Trans. 2 1990, 1005-1010.
7. [6a] R. Schudel, H. Mayer, J. Metzcer, R. Rüegg, O. Isler, Helv. Chim. Acta 1963, 66, 636-648.
8. [6b] Although published some 60 years ago, the original work on para-tocopheryl quinone is still most valuable: W. John, Z. Physiol. Chem. 1938, 252, 222-224.
9. [6c] W. John, E. Dietzl, W. Emte, Z. Physiol. Chem. 1939, 257, 173.
10. The reductant can be either a separate coreactant, cf. ref. [2], or the "former" 5a-substituent, cf.: T. Rosenau, W. D. Habicher, Chem. Pharm. Bull. 1997, 45, 1080-1084.
11. [8a] I. Jurna, T. L. Yaksh, Prog. Pharmacol. Clin. Pharmacol. 1993, 10, 1.
12. [8b] G. Kuschinsky, H. Lüllmann, H. (Eds.), Kurzes Lehrbuch der Pharmakologie und Toxikologie, Thieme, Stuttgart, 1993, p. 289.
13. 2O in chloroform: D. C. Dahlin, D. Sidney, J. Med. Chem. 1982, 25(7), 885.
14. Reactivity and preparation of ortho-quinone methides: [10a] L. Jurd, J. N. Roitman, Tetrahedron 1979, 35, 1567-1574.
15. Trapping of 4 in organic syntheses with vinyl type structures: [10b] D. A. Bolon, J. Org. Chem. 1970, 35, 3666-3671.
16. [10c] T. Rosenau, W. D. Habicher, A. Potthast, P. Kosma, Synlett 1999, 3, 291-294.
17. Formation of dimeric products other than spiro-dimer 5 is a sensitive indicator for detection of homolytic processes in a reaction system. On the basis of these reactions, 1 is frequently applied as a reporter molecule for homolytic reactions, especially if the radical concentration is too low for EPR detection, or if the system is unsuitable for EPR experiments.
18. M. Freed, J. Labelled Compd. Radiopharm. 1978, 15, 637.
19. By setting the values for the two dihedrals in 10° intervals, a 36 × 36 matrix of optimized energies was obtained for compounds 8a to 81. For many dihedrals, the proximity of substituent atoms and the tocopherol moiety resulted in strong steric repulsion, and thus in unstable geometries. The additional steric constraint with bulky substituents, such as in 8k or in 81, was clearly evident.
20. The exact values for the dihedral angles C-6-C-5-C-5a-O and C-5-C-5a-O-C-1′ are 46.2° and -103.5° for Toc-acetaminophen (8a), 45.9° and -101.4° for 8i, and 46.4° and -101.9° for 8j. The stabilization gained by adopting this geometry can be visualized by considering the rotational barrier for the bond C-5a-O, which corresponds to a change of the dihedral angle C-5-C-5a-O-C-1′. For deprotonated Tocacetaminophen (8a) the rotational barrier was 31 kJ/mol, and the values for 8i and 8j were 26 kJ/mol and 29 kJ/mol, respectively. For the bulky 4′-N-acyl substituents (8k and 81) the rotational barrier was lower at 23 kJ/mol. Interestingly, neutral (i.e., not deprotonated) 8a exhibited only a shallow energy minimum of 19 kJ/mol at slightly altered dihedral angles (C-6-C-5-C-5a-O: 45.4° and C-5-C-5a-O-C-1′: -104.9°).
21. A. J. Bard, R. Parsons, J. Jordan, Standard Potentials in Aqueous Solutions, Marcel Dekker, New York, 1985.
22. [16a] V. W. Bowry, K. U. Ingold, R. Stocker, Biochem. J. 1992, 288, 341-344.
23. [16b] J. Neuzil, S. R. Thomas, R. Stocker, Free Radical Biology Medicine 1997, 22, 57-71.
24. [16c] S. R. Husain, J. Cillard, P. Cillard, J. Am. Oil Chem. Soc. 1987, 64, 109-111.
25. [17a] A. Kontush, B. Finckh, B. Karten, A. Kohlschütter, U. Beisiegel, J. Lipid Res. 1996, 37, 1436-1448.
26. [17b] Y. Yoshida, J. Tsuchiya, E. Niki, Biochim. Biophys. Acta 1994, 1200, 85-92.
27. [17c] K. Mukai, K. Sawada, Y. Kohno, J. Terao, Lipids 1993, 28, 747-752.
28. [17d] P. K. Witting, V. C. Bowry, R. Stocker, FEBS Lett. 1995, 375, 45-49.
29. [18a] IUPAC-IUB Commission on Biochemical Nomenclature (CBN), Arch. Biochim. Biophys. 1974, 165, 1-8.
30. [18b] IUPAC-IUB, Eur. J. Biochim. 1982, 123, 473-475.
31. [19a] S. Urano, M. Matsuo, Chem. Pharm. Bull. 1980, 28(7), 1992.
32. [19b] S. Brownstein, K. U. Ingold, J. Org. Chem. 1989, 54(3), 561-569.